NCT00803062 · OUTCOME

Extent of Nicotine Dependence

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer · Source last updated 2019-07-23

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Up to 5 years

What was measured

Assessed from answers the patients provide to a questionnaire. Will be assessed for associations with progression and/or death.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Assessed from answers the patients provide to a questionnaire. Will be assessed for associations with progression and/or death.
reporting Status: NOT_POSTED
time Frame: Up to 5 years
title: Extent of Nicotine Dependence
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice